Ticker Details
BioAge Labs, Inc.
IPO Date:	September 26, 2024
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$435.1M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.55 | 4.21%
Avg Daily Range (30 D):	$1.16 | 5.63%
Avg Daily Range (90 D):	$0.91 | 4.66%

Institutional Daily Volume
Avg Daily Volume:	.44M
Avg Daily Volume (30 D):	.95M
Avg Daily Volume (90 D):	.59M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	74
Avg Trade Size (Sh.) (90 D):	65

Institutional Trades
Total Institutional Trades:	284
Avg Institutional Trade:	$1.51M
Avg Institutional Trade (30 D):	$1.19M
Avg Institutional Trade (90 D):	$1.55M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.5M
Avg Closing Trade (30 D):	$1.19M
Avg Closing Trade (90 D):	$1.5M
Avg Closing Volume:	99.86K

News

Aug 5, 2026 @ 8:50 PM BioAge Labs Reports Second Quarter 2026 Financial ... Source: Na

Jun 16, 2026 @ 12:00 PM BioAge Labs Announces First Participant Dosed in Q... Source: Bioage Labs, Inc.

May 22, 2026 @ 1:00 PM BioAge Labs to Present at Upcoming Investor Confer... Source: Na

May 20, 2026 @ 1:50 PM Cell-Based Therapies Poised to Disrupt Multi-Billi... Source: Market News Updates

Apr 21, 2026 @ 11:00 AM BioAge Reports Positive Phase 1 Data for BGE-102, ... Source: Bioage Labs, Inc.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-2.39	$-.58	$-.52
Diluted EPS	$-2.39	$-.58	$-.52
Revenue	$10.36M	$2.45M	$2.77M
Gross Profit
Net Income / Loss	$-94.46M	$-26.1M	$-22.25M
Operating Income / Loss	$-106.27M	$-29.33M	$-25.38M
Cost of Revenue
Net Cash Flow	$-146.31M	$-167.81M	$52.92M
PE Ratio